Evidence map›Paper›PMID 28989989›Full record

ArticleCurrent opinion in toxicology2017

Immunotoxicology: A brief history, current status and strategies for future immunotoxicity assessment.

Dori Germolec, Robert Luebke, Andrew Rooney, Kelly Shipkowski, Rob Vandebriel, Henk van Loveren

Abstract read
In one paragraph

Article in Current opinion in toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Pollution and health: a progress update.The Lancet. Planetary health · 2022
    Review
  6. Rotenone ModulatesFrontiers in immunology · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Journal of immunotoxicology · 2020
    Article
  12. Novel Acaricidal Drug Fluazuron Causes Immunotoxicity via Selective Depletion of Lymphocytes T CD8.Evidence-based complementary and alternative medicine : eCAM · 2019
    Article
  13. Immunotoxicological Evaluation ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dori GermolecToxicology Branch, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
Robert LuebkeCardiopulmonary and Immunotoxicology Branch, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC.
Andrew RooneyOffice of Health Assessment and Translation, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
Kelly ShipkowskiToxicology Branch, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
Rob VandebrielCentre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Henk van LoverenDepartment of Toxicogenomics, Maastricht University, Maastricht, the Netherlands.

Funding

Integrated Health Assessments for the National Toxicology ProgramZIAES103317 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ROONEY, ANDREW · 2016 to 2019
$24.4M
Intramural NIH HHS Z99 ES999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28989989
PMCPMC5629009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.